Lumos Pharma to sell its Priority Review Voucher ERVEBO to MSD ruchika2 Aug 2020 4:00 AM GMTBased upon an agreed valuation of $100 million Merck will pay Lumos $60 million
Merck HIF-2α Inhibitor MK-6482 gets Breakthrough Therapy Designation from USFDA ruchika31 July 2020 3:30 AM GMTKenilworth: Merck, known as MSD outside the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has granted Breakt...
HealthQuad raises Rs 514 crore for second fund Farhat Nasim18 July 2020 4:15 AM GMTHealthQuad said the fundraise entrusts strong and positive belief in disruptive healthcare business models that will address the imminent and...
Merck, Foghorn enter over Rs 3197 crore deal to Discover, Develop Novel Oncology Therapeutics ruchika10 July 2020 9:59 AM GMTCambridge: Foghorn Therapeutics Inc., a company advancing an unprecedented class of therapeutics targeting the chromatin regulatory system in oncology,...
Merck division Acquires US Rights to SENTINEL Brand of Combination Parasiticides for Companion Animals ruchika5 July 2020 3:30 AM GMTMadison: Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Kenilworth, N.J., U...
Merck bladder cancer treatment BAVENCIO gets USFDA approval Farhat Nasim1 July 2020 7:00 AM GMTNew York: EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, and Pfizer Inc. today announced that the U...
Delhi HC restrains firm from infringing Merck diabetes drug Sitagliptin Farhat Nasim28 Jun 2020 5:45 AM GMT'It appears that if Merck Sharp & Dohme Corp are not protected, their interest would get jeopardized. Furthermore, it would also affect the interest...
Merck goes against Dr Reddys alleging patent infringement of diabetes drug Januvia, Janumet Farhat Nasim28 Jun 2020 5:15 AM GMTMerck in its petition filed on June 23, said Dr Reddys had submitted ANDAs (abbreviated new drug application) to the US FDA seeking approval from the...
Merck bags US Patents for Foundational CRISPR-Cas9 Technology ruchika12 May 2020 7:04 AM GMTGermany: Merck has announced that two of its CRISPR-Cas9-assisted genome-editing patents have been allowed in the United States. These allowances provi...
Merck Foundation Announce 'Stay at Home' Media Recognition Awards for Asian Journalists Medical Dialogues Bureau15 April 2020 3:30 AM GMTMumbai: Merck Foundation, the philanthropic arm of Merck KGaA Germany, announced the call for applications for 'Stay at Home' Media Recognition Awards ...
SGLT2 inhibitors can lead to serious genital infection: USFDA warning Ruby31 Aug 2018 3:30 AM GMTThe SGLT2 inhibitors approved by the FDA include Johnson and Johnson's Invokana, Eli Lilly & Co's Jardiance, as well as those from Bristol-Myers Sq...
AstraZeneca wins FDA breakthrough status for durvalumab savita18 Feb 2016 3:46 AM GMTLONDON: The U.S. Food and Drug Administration has granted breakthrough therapy designation to AstraZeneca's biggest new drug hope durvalumab as a...
